Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 1839-1841, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voortman, A.
Right arrow Articles by Verhoef, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voortman, A.
Right arrow Articles by Verhoef, P.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2001;47:1839-1841.)
© 2001 American Association for Clinical Chemistry, Inc.

Technical Briefs

Optimal Time Interval between Repeated Blood Sampling for Measurements of Total Homocysteine in Healthy Individuals

Annemarie Voortman1, Alida Melse-Boonstra1,2, Johanna M. Schulz1, Jan Burema1, Martijn B. Katan1,2 and Petra Verhoef1,2a

1 Division of Human Nutrition and Epidemiology, Wageningen University, 6700 EV Wageningen, The Netherlands

2 Wageningen Centre for Food Sciences, 6703 GW Wageningen, The Netherlands

aaddress correspondence to this author at: Wageningen Centre for Food Sciences/Division of Human Nutrition and Epidemiology, Wageningen University, PO Box 8129, 6700 EV Wageningen, The Netherlands; fax 31-317-485369, e-mail Petra.Verhoef@Staff.NutEpi.WAU.nl

Many studies have shown that increased plasma concentrations of total homocysteine (tHcy) are associated with cardiovascular disease (1). Like most biological variables, plasma tHcy fluctuates within an individual around a long-term mean (2)(3). tHcy measurements often are based on a single blood sample. Taking the mean of two or more repeated measurements will reduce the error attributable to within-subject biological fluctuations and reflect more closely a person’s true mean tHcy value within a certain period. However, as the time interval between two repeated measurements becomes shorter, the values become more similar and the error reduction diminishes. In that case, the benefit of taking the mean of two measurements is not fully used. On the other hand, intervals that are too long (several weeks) may compromise the compliance of study participants and allow long-term seasonal changes (4)(5).

Several studies on the weekly and monthly biological variation, as expressed by the CV, in plasma tHcy concentrations have been published (Table 1 ). From these studies, no conclusions can be drawn about the optimal time interval between two repeated samples to obtain a sufficiently precise estimate of the true tHcy concentration within a predefined period. The optimal time interval is reached when the interval-specific CV does not increase further with increasing time intervals.


View this table:
[in this window]
[in a new window]
  		Table 1. Biological variation in plasma tHcy concentrations according to several studies using weekly through monthly sampling strategies.

The aim of this study was to determine how many days between two samplings within 1 week are needed to reach the maximum biological variation in tHcy. Our findings may be useful in studies involving estimates of an individual’s true mean concentration of tHcy.

The participants in this study were six male and nine female healthy volunteers, ages 19–46 years. Use of medication or . . . [Full Text of this Article]


Appendix 1


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
G. Soletormos, A. Semjonow, P. E.C. Sibley, R. Lamerz, P. H. Petersen, W. Albrecht, P. Bialk, M. Gion, F. Junker, H.-P. Schmid, et al.
Biological Variation of Total Prostate-Specific Antigen: A Survey of Published Estimates and Consequences for Clinical Practice
Clin. Chem., August 1, 2005; 51(8): 1342 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. P Hannon-Fletcher, N. C Armstrong, J. M Scott, K. Pentieva, I. Bradbury, M. Ward, J. Strain, A. A Dunn, A. M Molloy, M. A Kerr, et al.
Determining bioavailability of food folates in a controlled intervention study
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 911 - 918.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. Melse-Boonstra, C. E West, M. B Katan, F. J Kok, and P. Verhoef
Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 424 - 429.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.